Open Access Editorial

An Established Technology Gets a New Application: Reimplantation of Autologous Ovarian Tissue to Treat Menopausal Symptoms

BM Petrikovsky1*, EV Zharov2 and M Cohen3

1Chairman of Obstetrics and Gynecology, Nassau University Medical Center, USA

2Russian Federation Academy of Science, Russia

3Attending Emeritus, Hartford Hospital, USA

Corresponding Author

Received Date: April 12, 2019;  Published Date: April 18, 2019


In 1954 and 1956, Deanesly [1] and Green, et al. [2] were one of the first to experiment with the freezing and thawing of animal ovarian tissue. In the first half of the 20th century, the art of tissue cryopreservation was at its infancy with glycerol being the only cryoprotectant available [3]. Glycerol is a poor cryoprotectant and, therefore, early research showed very limited success [4]. Additional cryoprotectants became available during the 1990s leading to successful ovarian tissue cryopreservation, transplantation, and resumption of fertility studies in animals and humans [3,5,6].

Signup for Newsletter
Scroll to Top